Gene therapy comes of age Journal Article


Authors: Dunbar, C. E.; High, K. A.; Joung, J. K.; Kohn, D. B.; Ozawa, K.; Sadelain, M.
Article Title: Gene therapy comes of age
Abstract: After almost 30 years of promise tempered by setbacks, gene therapies are rapidly becoming a critical component of the therapeutic armamentarium for a variety of inherited and acquired human diseases. Gene therapies for inherited immune disorders, hemophilia, eye and neurodegenerative disorders, and lymphoid cancers recently progressed to approved drug status in the United States and Europe, or are anticipated to receive approval in the near future. In this Review, we discuss milestones in the development of gene therapies, focusing on direct in vivo administration of viral vectors and adoptive transfer of genetically engineered T cells or hematopoietic stem cells. We also discuss emerging genome editing technologies that should further advance the scope and efficacy of gene therapy approaches.
Keywords: unclassified drug; review; nonhuman; united states; t lymphocyte; gene; immune system; europe; genetic engineering; gene therapy; lentivirus vector; retrovirus vector; adoptive transfer; genome; hematopoietic stem cell; eye disease; genetic disorder; blindness; severe combined immunodeficiency; immunopathology; degenerative disease; heritability; virus vector; hemophilia; disease; cell; lymphatic system disease; drug; aromatic levo amino acid decarboxylase; spinal muscular atrophy; human; priority journal; gene editing; neurturin; adeno associated virus vector; alipogene tiparvovec; nusinersen; retinal pigment epithelium 65; spumavirus vector; strimvelis; visual pigment; hyperlipoproteinemia type 1
Journal Title: Science
Volume: 359
Issue: 6372
ISSN: 0036-8075
Publisher: American Association for the Advancement of Science  
Date Published: 2018-01-12
Start Page: eaan4672
Language: English
DOI: 10.1126/science.aan4672
PROVIDER: scopus
PUBMED: 29326244
DOI/URL:
Notes: Review -- Export Date: 1 February 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michel W J Sadelain
    583 Sadelain